4D pharma
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company..
Debt to Assets
| Q2 2020 | 39946000 | 8.48M | 21.25% |
|---|---|---|---|
| Q4 2020 | 35421000 | 7.45M | 21.04% |
| Q2 2021 | 47647000 | 7.98M | 16.76% |
| Q4 2021 | 58794000 | 26.37M | 44.87% |
LBPSW Balance Sheet (Q2 2020 – Q4 2021)
| Q4 2021 | Q2 2021 | Q4 2020 | Q2 2020 | |
|---|---|---|---|---|
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | 20.97M | 20.74M | 8.77M | 10.02M |
Short term investments | 0 | 0 | 0 | 0 |
Net receivables | 0 | 0 | 0 | 0 |
Inventory | 0 | 305K | 291K | 212K |
Other current assets | 13.52M | 8.65M | 7.65M | 10.27M |
Total current assets | 34.50M | 29.70M | 16.72M | 20.51M |
Non-current assets: | ||||
Property, Plant and Equipment | 4.87M | 3.98M | 4.49M | 5.06M |
Goodwill | 13.01M | 0 | 9.41M | 0 |
Intangible assets | 6.12M | 0 | 4.61M | 0 |
Long term investments | 0 | 0 | 0 | 0 |
Other non-current assets | 269K | 13.96M | 177K | 14.37M |
Total non-current assets | 24.29M | 17.94M | 18.69M | 19.43M |
Total assets | 58.79M | 47.64M | 35.42M | 39.94M |
Liabilities | ||||
| Current liabilities: | ||||
Accounts payable | ||||
Deferred revenue | 0 | 0 | 223K | 0 |
Short term debt | 108K | 74K | 73K | 73K |
Total current liabilities | 6.61M | 7.03M | 6.45M | 6.49M |
| Non-current liabilities: | ||||
Long term debt | 12.69M | 936K | 986K | 1.02M |
Deferred tax | 0 | 0 | 0 | 0 |
Other non-current liabilities | 7.05M | 0 | -306K | 0 |
Total non-current liabilities | 19.76M | 948K | 999K | 1.99M |
Total liabilities | 26.37M | 7.98M | 7.45M | 8.48M |
| Data source | Data source | Data source |